Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
388 studies found for:    shingles
Show Display Options
RSS Create an RSS feed from your search for:
shingles
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
Systems Biology of Zoster Vaccine (ZOSTAVAX®) in Young and Elderly
Condition: Shingles
Intervention: Biological: ZOSTAVAX
2 Recruiting Optimal Timing of Zoster Vaccine After Zoster Illness
Condition: Shingles
Intervention: Biological: Zostavax
3 Completed Shingles Prevention Study
Conditions: Herpes Zoster;   Postherpetic Neuralgia
Interventions: Biological: Varicella-zoster vaccine;   Biological: Placebo
4 Completed Use of an Electronic Medical Record in the Primary Care Setting to Improve Herpes Zoster Vaccination Rates
Condition: Herpes Zoster Disease
Intervention: Other: An informational packet regarding shingles and the HZV was sent to patients identified by the EMR
5 Recruiting Immune Response to Shingles Vaccination
Condition: Shingles
Intervention: Drug: Zoster Vaccine Live
6 Completed Safety, Tolerability, and the Body's Ability to Develop Resistance to an Investigational Vaccine for Shingles (V211-007)
Condition: Shingles
Interventions: Biological: zoster vaccine live (Oka/Merck);   Biological: Comparator: placebo (unspecified)
7 Completed Study to Evaluate Efficacy, Safety and Immunogenicity of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 50 Years and Older
Condition: Herpes Zoster
Interventions: Biological: Herpes Zoster Vaccine GSK1437173A;   Biological: Placebo
8 Completed
Has Results
Safety, Tolerability, and Immunogenicity of a Booster Dose of Zoster Vaccine, Live (V211-029)
Conditions: Herpes Zoster;   Varicella-zoster Vaccine
Intervention: Biological: Zoster Vaccine, Live
9 Completed Study to Evaluate Efficacy, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 70 Years and Older
Condition: Herpes Zoster
Interventions: Biological: Herpes Zoster Vaccine GSK1437173A;   Biological: Placebo
10 Completed
Has Results
T Cell Responses to Varicella Zoster Virus (VZV) Vaccine SLVP020
Condition: Herpes Zoster
Intervention: Biological: Zostavax™
11 Active, not recruiting ZOSTAVAX™ (Zoster Vaccine Live) Long-term Effectiveness Study (V211-024)
Conditions: Herpes Zoster;   Shingles
Intervention: Biological: ZOSTAVAX™
12 Completed A Study of FV-100 Versus Valacyclovir in Patients With Herpes Zoster
Conditions: Herpes Zoster;   Shingles
Interventions: Drug: valacyclovir;   Drug: FV-100;   Drug: Valacyclovir placebo;   Drug: FV-100 placebo
13 Active, not recruiting Study to Evaluate Immunogenicity and Safety of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine at 9 and 10 Years After Vaccine Administration and Assessment of Re-vaccination With 2 Additional Doses at 10 Years After Initial Vaccination, in Healthy Subjects Aged 60 Years of Age(YOA) and Older
Condition: Herpes Zoster
Intervention: Biological: Herpes Zoster Vaccine GSK1437173A
14 Recruiting Cross-vaccination Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK 1437173A) in Subjects Who Previously Received Placebo in ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) Studies.
Condition: Herpes Zoster
Intervention: Biological: Herpes Zoster Vaccine GSK1437173A
15 Recruiting Safety and Tolerability of Herpes Zoster Vaccine Rheumatologic Patients
Condition: Herpes Zoster
Intervention: Biological: Zostavax vaccine
16 Recruiting A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine and Assessment of 1 or 2 Additional Doses in Two Subgroups of Older Adults
Condition: Herpes Zoster
Intervention: Biological: Herpes Zoster Vaccine GSK1437173A
17 Active, not recruiting Vitamin D Supplementation And Varicella Zoster Virus Vaccine Responsiveness In Older Long-Term Care Residents
Conditions: Immunosenescence;   Shingles
Intervention: Biological: Varicella Zoster Virus Vaccine (Zostavax)
18 Completed
Has Results
A Study of an Investigational Zoster Vaccine, in Subjects With a History of Herpes Zoster (V211-014)
Condition: Herpes Zoster
Interventions: Biological: zoster vaccine live (ZOSTAVAX™);   Biological: Comparator: Placebo
19 Completed
Has Results
A Study to Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chickenpox)(V211-010)(COMPLETED)
Condition: Herpes Zoster
Interventions: Biological: Comparator: zoster vaccine live (Oka/Merck) refrigerated formulation;   Biological: Comparator: zoster vaccine live (Oka/Merck) frozen formulation
20 Active, not recruiting Comparison of a Live Herpes Zoster Vaccine and a Recombinant Vaccine in 50-59 and 70-85 Year Olds
Conditions: Shingles;   Herpes Zoster
Interventions: Biological: Zostavax;   Biological: HZ/su vaccine;   Biological: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.